| Identification | More | [Name]
cis-13-Docosenoamide | [CAS]
112-84-5 | [Synonyms]
13-DOCOSENAMIDE
13Z-DOCOSENAMIDE
AKAWAX E-BEADS
AKAWAX E-MICROBEADS
ARMOSLIP E
CIS-13-DOCOSENAMIDE
CIS-13-DOCOSENOAMIDE
ERUCAMIDE
ERUCIC AMIDE
ERUCYLAMIDE
(z)-13-docosenamide
(13Z)-13-Docosenamide
13-Docosenamide,(Z)-
Armid E
cis-13-docosenamid
Crodamide E, ER
Erucic acid amide
erucicacidamide
Euracamide
Kemamide E | [EINECS(EC#)]
204-009-2 | [Molecular Formula]
C22H43NO | [MDL Number]
MFCD00882379 | [Molecular Weight]
337.58 | [MOL File]
112-84-5.mol |
| Chemical Properties | Back Directory | [Appearance]
Beige flakes with a fatty odor | [Melting point ]
75-85 °C
79-81 °C (lit.) | [Boiling point ]
473.86°C (rough estimate) | [density ]
0.9417 (rough estimate) | [vapor pressure ]
0-0Pa at 25℃ | [refractive index ]
1.5614 (estimate) | [Fp ]
230 °C
| [storage temp. ]
0-6°C | [solubility ]
Soluble in DMSO (up to at lease 40 mg/ml) or in Water (up to at least 25 mg/ml with warming) | [form ]
solid | [pka]
16.61±0.40(Predicted) | [color ]
Off-white | [Stability:]
Stable. Incompatible with strong oxidizing agents. | [Water Solubility ]
PRACTICALLY INSOLUBLE | [Stability]
Stable. Incompatible with strong oxidizing agents. | [InChIKey]
UAUDZVJPLUQNMU-KTKRTIGZSA-N | [LogP]
8 | [Use]
cis-13-Docosenoamide(112-84-5) permitted additive to adhesives used in food packaging. | [CAS DataBase Reference]
112-84-5(CAS DataBase Reference) | [NIST Chemistry Reference]
13-Docosenamide, (z)-(112-84-5) | [EPA Substance Registry System]
112-84-5(EPA Substance) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36:Wear suitable protective clothing .
S37/39:Wear suitable gloves and eye/face protection . | [WGK Germany ]
1
| [HS Code ]
29241990 | [Hazardous Substances Data]
112-84-5(Hazardous Substances Data) |
| Hazard Information | Back Directory | [Description]
Erucamide is also known as 13-Docosenamide or Erucylamide. It is in the form of white flakes or beads. It is soluble in isopropanol, slightly soluble in alcohol and acetone.1 In industry, cis-13-docosenoamide is used in the formulations of anti-adhesive agents, lubricants, and lubricant additives to reduce their friction coefficient and to make films easier to handle.2 It is used as a standard to determine fatty acid amides in polyethylene packaging film by GC/MS.3 | [Chemical Properties]
Solid. Soluble in isopropanol; slightly soluble in
alcohol and acetone. Combustible. | [Uses]
13-Docosenamide is the amide of docosenoic acid. It was first identified in the cerebrospinal fluid of sleep-deprived cats. It has also been detected in the cerebrospinal fluid of rats and humans. 13-Docosenamide causes reduced mobility and slightly lessened awareness in rats, whereas 9-octadecenamide induces physiological sleep.[Cayman Chemical] | [Uses]
Plastic additive 21 is a plasticizer; used in preparation of natural mineral modified degradable polymer flame-retardant composite material. | [Definition]
ChEBI:Erucamide is a primary fatty amide resulting from the formal condensation of the carboxy group of erucic acid with ammonia. It is commonly used as a slip additive in the plastic manufacturing industry. It has a role as a human metabolite, a rat metabolite, a mammalian metabolite, a plant metabolite and an EC 3.1.1.7 (acetylcholinesterase) inhibitor. It is functionally related to an erucic acid. | [Preparation]
Erucamide is prepared by reaction of erucic acid with anhydrous ammonia. The reaction of erucic acid with anhydrous ammonia is as follows: C22H42O2 + NH3 → C22H43NO2. | [General Description]
Erucamide is a migratory additive that is commonly placed in polyolefin films to reduce their coefficient of friction (COF), a good attribute for high speed packaging operations. | [Flammability and Explosibility]
Nonflammable | [Biological Activity]
13-Docosenamide is the amide of docosenoic acid. It was first identified in the cerebrospinal fluid of sleep-deprived cats. It has also been detected in the cerebrospinal fluid of rats and humans. 13-Docosenamide causes reduced mobility and slightly lessened awareness in rats, whereas 9-octadecenamide induces physiological sleep. | [storage]
Store at -20°C | [References]
1) Li et al. (2017), Antidepressant and anxiolytic-like behavioral effects of erucamide, a bioactive fatty acid amide, involving the hypothalamus-pituitary-adrenal axis in mice; Neurosci. Lett. 640 6 |
|
|